ERBB2 and cancer: On immunohistochemical staining, the cancer cells were strongly positive for estrogen receptor (90% of cells positive) and progesterone receptor (> 99% of cells positive), negative for human epidermal growth factor receptor 2 (HER-2), and the Ki-67 score was 10%.